What is Aclaris Therapeutics's common stock?

Aclaris Therapeutics (ACRS) reported common stock of $1K in Q1 2026.

How has Aclaris Therapeutics's common stock changed year-over-year?

Aclaris Therapeutics's common stock decreased by 0.0% year-over-year, from $1K to $1K.

What is the long-term trend for Aclaris Therapeutics's common stock?

Over 4 years (2021 to 2025), Aclaris Therapeutics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $1K to $1K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Aclaris Therapeutics ACRS Common Stock

Common Stock at other companies

IncyteINCY

400M0.0%

Corvus PharmaceuticalsCRVS

$8K+14.3%

Upstream Bio, Inc.UPB

$54K+1.9%

Avalo TherapeuticsAVTX

200M0.0%

Shattuck Labs, Inc.STTK

300M0.0%

Apogee Therapeutics, Inc.APGE

$1K0.0%

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's common stock?: Aclaris Therapeutics (ACRS) reported common stock of $1K in Q1 2026.
How has Aclaris Therapeutics's common stock changed year-over-year?: Aclaris Therapeutics's common stock decreased by 0.0% year-over-year, from $1K to $1K.
What is the long-term trend for Aclaris Therapeutics's common stock?: Over 4 years (2021 to 2025), Aclaris Therapeutics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $1K to $1K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).